These results seem to show that IGF2BP3-positive vascular lesions are malignant, therefore the presence of IGF2BP3-positive vasoformative cells on the surgical margins of angiosarcoma and EHE should be judged as “margin positive”, and the followed additional resection. The gene discussed is IGF2BP3; the disease is angiosarcoma.